Skye Bioscience SKYE
NASDAQ SKYE
$1.68 +0.08 (+5.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Change in Accured Expenses (2012 - 2026)

Updated

Skye Bioscience (SKYE) posted Change in Accured Expenses of $456,174 for Q2 2026, up 115.3% from $211,893 a year earlier.

Analysis

Skye Bioscience (SKYE) Change in Accured Expenses (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Skye Bioscience was -$177,458; for FY2025, it came in at $155,219, down 31.3% from FY2024.

  • Annual Change in Accured Expenses has declined for three consecutive years, though with a five-year compound annual growth rate of 28.6% (FY2020 to FY2025).
  • In prior years, Skye Bioscience's Change in Accured Expenses was $225,874 in FY2024 (-2.1%), $230,647 in FY2023 (-26.4%), $313,284 in FY2022 (+10.7%) and $282,903 in FY2021 (+541.7%).
  • The Q2 2026 figure stands as the highest quarterly Change in Accured Expenses in data going back to Q4 2012.
  • On a year-over-year basis, Change in Accured Expenses increased in three of the last five quarters, with growth averaging 17.4%.
  • The strongest year-over-year quarter for Change in Accured Expenses in the past five years was Q4 2022, with growth of 123.7%; the weakest was Q3 2025, with a decline of 84.8%.
  • According to Business Quant data, Change in Accured Expenses for the three prior quarters was -$1.04 million (Q1 2026), $348,700 (Q4 2025) and $52,750 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Skye Bioscience 7.38 Mn 7.38 Mn - 456,174.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 456,174.00
Mar 31, 2026 -1.04 Mn
Dec 31, 2025 348,700.00
Sep 30, 2025 52,750.00
Jun 30, 2025 211,893.00
Mar 31, 2025 -458,124.00
Dec 31, 2024 210,985.00
Sep 30, 2024 346,697.00
Jun 30, 2024 203,111.00
Mar 31, 2024 -534,919.00
Dec 31, 2023 242,551.00
Sep 30, 2023 -268,099.00
Jun 30, 2023 121,428.00
Mar 31, 2023 134,767.00
Dec 31, 2022 182,461.00
Sep 30, 2022 44,087.00
Jun 30, 2022 194,149.00
Mar 31, 2022 -107,413.00
Dec 31, 2021 81,569.00
Sep 30, 2021 150,374.00
API Access

Skye Bioscience Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=SKYE&period=max&api_key=YOUR_API_KEY